Clinical trial
Study of High Efficient Killing Cell Therapy for Advanced NSCLC
NCT03193567
Study timeline
Study start (actual)2017-09-14Date precision: day
Registry last updated2024-11-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancerunresolved
Interventions
HEKT cellBIOLOGICAL
Sponsors & collaborators
Ruijin Hospitallead sponsor
Shanghai Houchao Biotechnology Co., Ltdcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03193567 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.